MX2017008423A - Formulaciones transdérmicas. - Google Patents
Formulaciones transdérmicas.Info
- Publication number
- MX2017008423A MX2017008423A MX2017008423A MX2017008423A MX2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A
- Authority
- MX
- Mexico
- Prior art keywords
- transdermal formulations
- transdermal
- formulations
- directed
- present disclosure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
La presente exposición se dirige a composiciones transdérmicas y humectantes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462096148P | 2014-12-23 | 2014-12-23 | |
PCT/US2015/000302 WO2016105530A1 (en) | 2014-12-23 | 2015-12-23 | Transdermal formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017008423A true MX2017008423A (es) | 2017-10-26 |
Family
ID=55221489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017008423A MX2017008423A (es) | 2014-12-23 | 2015-12-23 | Formulaciones transdérmicas. |
Country Status (14)
Country | Link |
---|---|
US (3) | US20160193339A1 (es) |
EP (1) | EP3237013B1 (es) |
JP (2) | JP6836991B2 (es) |
KR (1) | KR20170117390A (es) |
CN (1) | CN107405298A (es) |
AU (1) | AU2015371253B2 (es) |
BR (1) | BR112017013329A2 (es) |
CA (1) | CA2968046A1 (es) |
EA (1) | EA035087B1 (es) |
ES (1) | ES2953955T3 (es) |
IL (1) | IL252062A0 (es) |
MX (1) | MX2017008423A (es) |
PH (1) | PH12017500836A1 (es) |
WO (1) | WO2016105530A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10272068B2 (en) | 2012-01-17 | 2019-04-30 | Tyme, Inc. | Pharmaceutical compositions and methods |
US10646552B2 (en) | 2012-01-17 | 2020-05-12 | Tyme, Inc. | Pharmaceutical compositions and methods |
US20130183263A1 (en) | 2012-01-17 | 2013-07-18 | Steven Hoffman | Pharmaceutical compositions and methods |
EP3247988A4 (en) | 2015-01-23 | 2018-12-19 | Vanderbilt University | A robust interferometer and methods of using same |
MX2019012476A (es) * | 2017-04-21 | 2020-02-12 | Hoffman Steven | Composiciones y metodos para tratar la retinopatia. |
WO2019055747A1 (en) * | 2017-09-15 | 2019-03-21 | Tyme, Inc. | TRANSDERMAL PREPARATIONS |
WO2020112766A1 (en) * | 2018-11-26 | 2020-06-04 | Steven Hoffman | Compositions and methods for treating nerve agent exposure |
US20200282014A1 (en) * | 2019-03-05 | 2020-09-10 | Hoffman Technologies Llc | Percutaneous anti-microbiota formulations |
CA3140042A1 (en) | 2019-05-14 | 2020-11-19 | Tyme, Inc. | Compositions and methods for treating cancer |
US20230165940A1 (en) * | 2020-04-08 | 2023-06-01 | Hoffman Technologies Llc | Methods of treating conditions characterized by insulin deficiency in animals |
US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61210024A (ja) * | 1985-03-14 | 1986-09-18 | Yamanouchi Pharmaceut Co Ltd | 外用塩酸ニカルジピン製剤 |
US4677131A (en) | 1985-11-01 | 1987-06-30 | Merck & Co., Inc. | Cyclic ureas as dermal penetration enhancers |
US5238933A (en) | 1991-10-28 | 1993-08-24 | Sri International | Skin permeation enhancer compositions |
US5618850A (en) * | 1995-03-09 | 1997-04-08 | Focal, Inc. | Hydroxy-acid cosmetics |
US20040121023A1 (en) | 1998-11-02 | 2004-06-24 | Victor Stevens | Composition to alleviate pain and topical method of applying same |
JP4271869B2 (ja) * | 1999-02-09 | 2009-06-03 | サムヤン コーポレイション | 経皮投与用抗嘔吐剤組成物およびこれを含む製剤 |
CN1167412C (zh) * | 2000-08-03 | 2004-09-22 | 浙江大学 | 一种经皮理疗用药物凝胶 |
DE10158199A1 (de) | 2001-11-27 | 2003-06-18 | Beiersdorf Ag | Juckreizstillende kosmetische und dermatologische Zubereitungen |
AU2012216593B2 (en) | 2002-11-01 | 2014-09-25 | Allergan Sales, Llc | Compositions and methods for transdermal oxybutynin therapy |
NZ546106A (en) | 2003-10-10 | 2008-10-31 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
US20060140988A1 (en) | 2004-12-23 | 2006-06-29 | Guohua Chen | Visco-supplement composition and methods |
WO2006118173A1 (ja) | 2005-04-28 | 2006-11-09 | Ono Pharmaceutical Co., Ltd. | 経皮吸収製剤 |
KR100658436B1 (ko) * | 2005-12-09 | 2006-12-27 | 한국화학연구원 | 아데노실코발라민 함유 피부질환 치료용 외용제 조성물 |
EP1800671A1 (de) * | 2005-12-23 | 2007-06-27 | Bayer Schering Pharma Aktiengesellschaft | Verwendung filmbildender Haarpflegepolymere und diese Polymere enthaltenden pharmazeutischen Zubereitungen und Pflaster |
KR101333100B1 (ko) * | 2005-12-23 | 2013-11-27 | 에피나믹스 게엠베하 | 폴리우레탄 군으로부터의 필름-형성 헤어 케어 폴리머의 용도 및 폴리머를 포함하는 약학적 제제와 패치 |
US9393218B2 (en) * | 2005-12-23 | 2016-07-19 | Epinamics Gmbh | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers |
CN101045041A (zh) * | 2007-04-29 | 2007-10-03 | 武汉兵兵药业有限公司 | 含布洛芬的巴布剂及其制备方法和应用 |
US7883487B2 (en) * | 2008-06-16 | 2011-02-08 | Shantha Totada R | Transdermal local anesthetic patch with injection port |
WO2013109610A1 (en) * | 2012-01-17 | 2013-07-25 | Steven Hoffman | Pharmaceutical compositions and methods |
CN110772311A (zh) * | 2012-11-02 | 2020-02-11 | 纽敦力公司 | 用于多种疾病治疗的化学消融制剂和方法 |
US11135297B2 (en) * | 2013-07-11 | 2021-10-05 | Pola Pharma Inc. | External-use composition producing foamed state upon use |
-
2015
- 2015-12-23 EA EA201791454A patent/EA035087B1/ru not_active IP Right Cessation
- 2015-12-23 CN CN201580069944.7A patent/CN107405298A/zh active Pending
- 2015-12-23 CA CA2968046A patent/CA2968046A1/en not_active Abandoned
- 2015-12-23 AU AU2015371253A patent/AU2015371253B2/en active Active
- 2015-12-23 JP JP2017528802A patent/JP6836991B2/ja active Active
- 2015-12-23 EP EP15828407.5A patent/EP3237013B1/en active Active
- 2015-12-23 BR BR112017013329A patent/BR112017013329A2/pt not_active IP Right Cessation
- 2015-12-23 KR KR1020177020147A patent/KR20170117390A/ko unknown
- 2015-12-23 MX MX2017008423A patent/MX2017008423A/es unknown
- 2015-12-23 WO PCT/US2015/000302 patent/WO2016105530A1/en active Application Filing
- 2015-12-23 ES ES15828407T patent/ES2953955T3/es active Active
-
2016
- 2016-03-11 US US15/067,677 patent/US20160193339A1/en not_active Abandoned
-
2017
- 2017-05-01 IL IL252062A patent/IL252062A0/en unknown
- 2017-05-05 PH PH12017500836A patent/PH12017500836A1/en unknown
-
2019
- 2019-03-05 US US16/292,811 patent/US10786574B2/en active Active
-
2020
- 2020-09-28 US US17/034,406 patent/US20210008214A1/en not_active Abandoned
- 2020-10-28 JP JP2020180706A patent/JP2021020955A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EA035087B1 (ru) | 2020-04-27 |
JP2021020955A (ja) | 2021-02-18 |
JP6836991B2 (ja) | 2021-03-03 |
PH12017500836A1 (en) | 2017-10-30 |
EP3237013B1 (en) | 2023-06-07 |
EP3237013A1 (en) | 2017-11-01 |
KR20170117390A (ko) | 2017-10-23 |
CA2968046A1 (en) | 2016-06-30 |
AU2015371253A1 (en) | 2017-06-01 |
EP3237013C0 (en) | 2023-06-07 |
US20160193339A1 (en) | 2016-07-07 |
US20210008214A1 (en) | 2021-01-14 |
IL252062A0 (en) | 2017-07-31 |
BR112017013329A2 (pt) | 2019-09-03 |
ES2953955T3 (es) | 2023-11-17 |
JP2017538694A (ja) | 2017-12-28 |
EA201791454A1 (ru) | 2017-12-29 |
CN107405298A (zh) | 2017-11-28 |
US20190192663A1 (en) | 2019-06-27 |
WO2016105530A1 (en) | 2016-06-30 |
AU2015371253B2 (en) | 2020-07-23 |
US10786574B2 (en) | 2020-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500836A1 (en) | Transdermal formulations | |
MX2023008686A (es) | Polinucleotidos moduladores. | |
MX2017008442A (es) | Uso de picolinamidas como fungicidas. | |
AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
TN2017000246A1 (en) | Anti-c10orf54 antibodies and uses thereof | |
MX2017001279A (es) | Usos y composiciones de la flagelina. | |
MX2015012334A (es) | Metodos y composiciones para el control de malezas. | |
TW201614041A (en) | Compositions for electronic devices | |
MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
MX2020004419A (es) | Polipeptidos fhbp meningococicos modificados. | |
MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
PT3102554T (pt) | Conversão de 2,3-butanodiol em butadieno | |
MX2017000862A (es) | Formulacion de factor viii. | |
MX2017006019A (es) | Apilimod para uso en el tratamiento de melanoma. | |
PH12016502530A1 (en) | Pharmaceutical compositions comprising dgla and use of same | |
PH12016501811A1 (en) | Cosmetic composition for skin moisturizing containing minerals and quinoa extract | |
MX2019010913A (es) | Analogos de deutetrabenazina, su preparacion y uso. | |
PH12017500499A1 (en) | Synthesis of ent-progesterone and intermediates thereof | |
MY167350A (en) | Fat-and-oil composition and chocolate | |
MX2016016612A (es) | Formulaciones estables de undecanoato de testosterona. | |
MX2017003165A (es) | Jabones antimicrobianos que contienen carvacrol y metodos de uso de los mismos. | |
MX2017005669A (es) | Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos. | |
IN2014CH00686A (es) | ||
UA95889U (uk) | Застосування екстракту солодкового кореня як противірусного засобу по відношенню до коронавірусів |